Company Filing History:
Years Active: 1998-1999
Title: Viera P Muzithras: Innovator in Human Cytomegalovirus Research
Introduction
Viera P Muzithras is a notable inventor based in Monroe, NY (US). She has made significant contributions to the field of virology, particularly in the study of human cytomegalovirus (HCMV). With a total of 2 patents, her work focuses on identifying non-essential genes of HCMV, which has implications for therapeutic development.
Latest Patents
Muzithras's latest patents include innovative methods for identifying non-essential genes of the human cytomegalovirus. One of her inventions involves the insertion of a .beta.-glucuronidase marker gene into a specified HCMV gene. This method allows researchers to determine if the product of the HCMV gene is expressed, thereby identifying non-essential genes for HCMV replication. Additionally, her invention provides a method for screening compounds that inhibit HCMV by utilizing the .beta.-glucuronidase marker gene, which can yield detectable fluorescing products or result in color changes in assay systems.
Career Highlights
Throughout her career, Viera P Muzithras has worked with prominent organizations, including American Cyanamid Company. Her experience in these companies has contributed to her expertise in virology and patent development.
Collaborations
Muzithras has collaborated with notable individuals in her field, including Thomas Richard Jones and Yakov Gluzman. These collaborations have likely enriched her research and innovation efforts.
Conclusion
Viera P Muzithras is a pioneering inventor whose work on human cytomegalovirus has the potential to advance therapeutic strategies. Her contributions to identifying non-essential genes and developing screening methods are significant in the field of virology.